M. Pinzani
Epidemiology · 2004–2021
A researcher in the Science corpus: 8 papers; trusts 12 researchers and is trusted by 24 researchers here, as inferred from the citation graph.
Subfields
- Epidemiology — 116 citations into it; #134 of 2,148 by trust here, #435 by citations
- Hepatology — 61 citations into it; #8 of 151 by trust here, #62 by citations
- Endocrinology, Diabetes and Metabolism — 28 citations into it
- Immunology — 16 citations into it
- Genetics — 7 citations into it
Whom M. Pinzani trusts overall
Their strongest outbound trust, strongest first, inferred from their citations.
Who trusts M. Pinzani overall
- TA Wynn
- V. Krizhanovsky
- A. Gressner
- Ralf Weiskirchen
- T. Kisseleva
- E. Seki
- Christian Trautwein
- Monica Yon
- J. Dowman
- G. Baffy
Papers from M. Pinzani's perspective
Ordered by how strongly the researchers M. Pinzani trusts endorse each paper. Same corpus, a different order for every researcher.
- TLR4 enhances TGF-beta signaling and hepatic fibrosis. (Nature Medicine)
- Autophagy regulates lipid metabolism (Nature)
- Genetic variation in PNPLA3 confers susceptibility to nonalcoholic fatty liver disease (Nature Genetics)
- Inhibiting triglyceride synthesis improves hepatic steatosis but exacerbates liver damage and fibrosis in obese mice with nonalcoholic steatohepatitis (Hepatology)
- Nonalcoholic steatohepatitis: association of insulin resistance and mitochondrial abnormalities. (Gastroenterology)
- Liver fibrosis and repair: immune regulation of wound healing in a solid organ (Nature reviews. Immunology)
- Interactions Between the Intestinal Microbiome and Liver Diseases (Gastroenterology)
- Nonalcoholic steatohepatitis (Current treatment options in gastroenterology)
- Of Mice and Not Men: Differences between Mouse and Human Immunology (Journal of Immunology)
- Liver fibrosis (Springer Seminars in Immunopathology)
Their papers
- Increased intestinal permeability in obese mice: new evidence in the pathogenesis of nonalcoholic steatohepatitis. (2007) — 858 citations
- Baveno VII – Renewing consensus in portal hypertension (2021) — 2,338 citations
- Liver fibrosis: Pathophysiology, pathogenetic targets and clinical issues. (2019) — 1,000 citations
- The multiple-hit pathogenesis of non-alcoholic fatty liver disease (NAFLD). (2016) — 2,765 citations
- Hepatic fibrosis: Concept to treatment. (2015) — 633 citations
- Liver stiffness measurement predicts severe portal hypertension in patients with HCV‐related cirrhosis (2007) — 734 citations
- Serum markers detect the presence of liver fibrosis: a cohort study. (2004) — 1,146 citations
- Liver fibrosis (2004) — 2,559 citations